NCT01007058View on ClinicalTrials.gov

Markers of Response to Intravesical Bladder Cancer Therapy

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Bladder Cancer
Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Flight Attendant Medical Research Institute

OTHER

lead

M.D. Anderson Cancer Center

OTHER

NCT01007058 - Markers of Response to Intravesical Bladder Cancer Therapy | Biotech Hunter | Biotech Hunter